GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Cash Conversion Cycle

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Cash Conversion Cycle : 80.95 (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Dimed Distribuidora de Medicamentos's Days Sales Outstanding for the three months ended in Dec. 2024 was 28.84.
Dimed Distribuidora de Medicamentos's Days Inventory for the three months ended in Dec. 2024 was 114.18.
Dimed Distribuidora de Medicamentos's Days Payable for the three months ended in Dec. 2024 was 62.07.
Therefore, Dimed Distribuidora de Medicamentos's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2024 was 80.95.


Dimed Distribuidora de Medicamentos Cash Conversion Cycle Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Cash Conversion Cycle Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.48 73.49 73.97 73.92 78.60

Dimed Distribuidora de Medicamentos Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.93 73.09 86.53 84.50 80.95

Competitive Comparison of Dimed Distribuidora de Medicamentos's Cash Conversion Cycle

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Cash Conversion Cycle falls into.


;
;

Dimed Distribuidora de Medicamentos Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Dimed Distribuidora de Medicamentos's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=33.11+116.44-70.95
=78.60

Dimed Distribuidora de Medicamentos's Cash Conversion Cycle for the quarter that ended in Dec. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=28.84+114.18-62.07
=80.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dimed Distribuidora de Medicamentos  (BSP:PNVL3) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Dimed Distribuidora de Medicamentos Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimed Distribuidora de Medicamentos Business Description

Traded in Other Exchanges
N/A
Address
Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos Headlines

No Headlines